Market Overview

Oncolytics Closes Offering of 8M Shares at $4/Share for Gross Proceeds of $32M

Related ONCY
US Stock Futures Signal Lower Start On Wall Street
Oncolytics Announces Collaborators to Present REOLYSIN Preclinical Data at ICOVT

Oncolytics Biotech Inc. (NASDAQ: ONCY) announced today that it has closed its previously announced underwritten public offering of 8.0 million common shares, at a public offering price of US$4.00 per common share.  The aggregate gross proceeds from the offering, before deducting underwriting discounts and commissions and offering expenses payable by Oncolytics, were approximately US$32.0 million.

Posted-In: News Offerings


Related Articles (ONCY)

Get Benzinga's Newsletters